Uroplasty to present Urgent PC, Macroplastique products study data at upcoming meetings

Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of clinical studies using Uroplasty's Urgent® PC Neuromodulation System and Macroplastique® urethral bulking agent products are scheduled to be presented at three upcoming professional meetings.  The meetings include the American College of Obstetricians and Gynecologists (ACOG) Annual Meeting in Washington DC, May 1 - 4; the American Urological Association (AUA) Annual Meeting in Washington DC, May 14 -17; and the American Society of Colon & Rectal Surgeons (ASCRS) Annual Meeting in Vancouver, Canada, May 14 -18.  

"There is a growing body of clinical evidence in support of our Urgent PC and Macroplastique products," said David Kaysen, President and CEO of Uroplasty.  "This new data, along with previously published studies, confirms the efficacy and safety of both our products for the treatment of patients who suffer daily with overactive bladder or stress urinary incontinence."  

ACOG Presentations

  • Percutaneous Tibial Nerve Stimulation vs. Validated Sham in those Exposed to Pharmacologic Therapy presented by Dr. Denise Elser, Illinois Urogynecology, Oak Lawn, IL
  • Percutaneous Tibial Nerve Stimulation (PTNS) and the Effect on Fecal Incontinence presented by Dr. Craig McCoy, Central Missouri Women's Healthcare, Marshall, MO

AUA Presentations

  • Insight into Percutaneous Tibial Nerve Stimulation: Critical Evaluation of the SUmiT Trial presented by Dr. Kenneth M. Peters, Beaumont Hospital, Royal Oak, MI
  • Long-term Durability of Polydimethylsiloxane Injection for Female Stress Urinary Incontinence Correlates with Histopathology presented by Dr. Gamal Ghoniem, Cleveland Clinic, Weston, FL
  • Treatment Interval Frequency of Percutaneous Tibial Nerve Stimulation: Preliminary Results from the STEP study presented by Dr. Scott A. MacDiarmid, Alliance Urology Specialists, Greensboro, NC

ASCRS Presentations

  • Percutaneous Tibial Nerve Stimulation and Effect on Fecal Incontinence: Results from Two Recent Overactive Bladder Trials presented by Dr. Steven Siegel, Metro Urology, Woodbury, MN.  
  • A Prospective, Single-Blinded, Placebo-Controlled Study into the Role of Percutaneous and Transcutaneous Tibial Nerve Stimulation for Fecal Incontinence presented by Dr. Anil George, St. Mark's Hospital, London, UK
  • Predictive Factors for Percutaneous Tibial Nerve Stimulation for Fecal Incontinence presented by Dr. Anil George, St. Mark's Hospital, London

SOURCE Uroplasty, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Stress and pain linked to worse outcomes in HER2-positive breast cancer patients